Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Soergel David
 2. Date of Event Requiring Statement (Month/Day/Year)
01/30/2014		 3. Issuer Name and Ticker or Trading Symbol
TREVENA INC [TRVN]
(Last)
(First)
(Middle)
C/O TREVENA, INC., 1018 WEST 8TH AVENUE, SUITE A		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Sr. VP, Clinical Development
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

KING OF PRUSSIA, PA 19406		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 27,217
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)   (1) 06/17/2023 Common Stock 98,660 $ 2.232 D  
Employee Stock Option (Right to Buy)   (2) 09/10/2020 Common Stock 36,929 $ 0.682 D  
Employee Stock Option (Right to Buy)   (3) 06/23/2021 Common Stock 570 $ 0.682 D  
Employee Stock Option (Right to Buy)   (4) 10/17/2022 Common Stock 32,258 $ 0.682 D  
Employee Stock Option (Right to Buy)   (5) 11/30/2019 Common Stock 1,814 $ 0.062 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Soergel David
C/O TREVENA, INC.
1018 WEST 8TH AVENUE, SUITE A
KING OF PRUSSIA, PA 19406		       Sr. VP, Clinical Development  

Signatures

/s/Derek Colla, Attorney-in-Fact for David Soergel 01/30/2014
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) One-sixteenth of the shares vested on August 3, 2013 and one-sixteenth vest quarterly thereafter.
(2) As of January 30, 2014, 33,870 of the shares underlying this option shall be vested. On April 8, 2014 and July 8, 2014, subject to the reorting person's continuous service to the issuer through such date, 2,419 and 640 shares underlying this option shall become vested, respectively.
(3) As of January 30, 2014, 522 of the shares underlying this option shall be vested. On April 8, 2014 and July 8, 2014, subject to the reporting person's continuous service to the issuer through such date, 37 and 11 shares underlying this option shall become vested, respectively.
(4) One-sixteenth of the shares vested on December 1, 2012 and one-sixteenth vest quarterly thereafter.
(5) One-eighth of the shares vested on May 23, 2010 and thereafter, on a quarterly basis measured from May 23, 2010, the option shall become vested with respect to an additional 1/16th of the total number of shares of stock subject to the option, until such time as the option is vested with respect to all the shares of stock subject to the option.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.